High-throughput screening for new psychoactive substances (NPS) in whole blood by DLLME extraction and UHPLC-MS/MS analysis

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1000, Issue , 2015, Pages 57-68

  Odoardi, Sara ^a   Fisichella, Marco ^a   Romolo, Francesco Saverio ^b,c   Strano Rossi, Sabina ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Blood; Clinical toxicology; DLLME; Forensic toxicology; NPS; UHPLC MS MS

Indexed keywords

BLOOD; CHEMICAL ANALYSIS; CHROMATOGRAPHY; DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; ORGANIC SOLVENTS; PHASE SEPARATION; SCREENING;

CLINICAL TOXICOLOGIES; DLLME; FORENSIC TOXICOLOGY; NPS; U-HPLC-MS;

EXTRACTION;

BENZOFURAN DERIVATIVE; CANNABINOID; CATHINONE; ILLICIT DRUG; KETAMINE; ORGANIC SOLVENT; PHENETHYLAMINE DERIVATIVE; PIPERAZINE DERIVATIVE; PSYCHOTROPIC AGENT; TRYPTAMINE DERIVATIVE;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; BODY FLUID; CONTROLLED STUDY; DISPERSIVE LIQUID LIQUID MICROEXTRACTION; FORENSIC TOXICOLOGY; HIGH THROUGHPUT SCREENING; HUMAN; LIMIT OF DETECTION; LIQUID PHASE MICROEXTRACTION; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROCEDURES; REPRODUCIBILITY; STATISTICAL MODEL;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIMIT OF DETECTION; LINEAR MODELS; LIQUID PHASE MICROEXTRACTION; PSYCHOTROPIC DRUGS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 84937899943     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2015.07.007     Document Type: Article

References (48)

1. http://www.unodc.org/documents/scientific/2014_Global_Synthetic_Drugs_Assessment_web.pdf.
2. New psychoactive substances in Europe, . http://www.emcdda.europa.eu/publications/2015/new-psychoactive-substances.
3. Kelly J.P. Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test. Anal. 2011, 3:439-453.
4. Zaitsu K., Katagi M., Tatsuno M., Sato T., Tsuchihashi H., Suzuki K. Recently abused beta-keto derivatives of 3,4-methylenedioxyphenylalkylamines: a review of their metabolisms and toxicological analysis. Forensic Toxicol. 2011, 29:73-84.
5. Coppola M., Mondola R. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as bath salts or plant food. Toxicol. Lett. 2012, 211:144-149.
6. Prosser J.M., Nelson L.S. The toxicology of bath salts: a review of synthetic cathinones. J. Med. Toxicol. 2012, 8:33-42.
7. Seely K.A., Lapoint J., Moran J.H., Fattore L. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 39:234-243.
8. Thornton S.L., Gerona R.R., Tomaszewski C.A. Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine and product quantification. J. Med. Toxicol. 2012, 8:310-313.
9. Jovel A., Felthous A., Bhattacharyya A. Delirium due to intoxication from the novel synthetic tryptamine 5-MeO-DALT. J. Forensic Sci. 2014, 59:844-846.
10. Torrance H., Cooper G. The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland. Forensic Sci. Int. 2010, 202:e62-e63.
11. Wikstrom M., Thelander G., Nystrom I., Kronstrand R. Two fatal intoxications with the new designer drug methedrone (4-methoxymethcathinone). J. Anal. Toxicol. 2010, 34:594-598.
12. Maskell P.D., De Paoli G., Seneviratne C., Pounder D.J. Mephedrone (4-methylmethcathinone)-related deaths. J. Anal. Toxicol. 2011, 35:188-191.
13. Carter N., Rutty G.N., Milroy C.M., Forrest A.R. Deaths associated with MBDB misuse. Int. J. Legal Med. 2000, 113:168-170.
14. Murray B.L., Murphy C.M., Beuhler M.C. Death following recreational use of designer drug bath salts containing 3,4-methylenedioxypyrovalerone (MDPV). J. Med. Toxicol. 2012, 8:69-75.
15. Adamowicz P., Zuba D., Byrska B. Fatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl) benzofuran (5-APB). Forensic Sci. Int. 2014, 245C:126-132.
16. Adamowicz P., Zuba D. Fatal intoxication with methoxetamine. J. Forensic Sci. 2015, 60:S264-S268. (Supply 1).
17. Sykutera M., Cychowska M., Bloch-Boguslawska E. A fatal case of pentedrone and alpha-pyrrolidinovalerophenone poisoning. J. Anal. Toxicol. 2015, 39:324-329.
18. Nagai H., Saka K., Nakajima M., Maeda H., Kuroda R., Igarashi A., Tsujimura-Ito T., Nara A., Komori M., Yoshida K. Sudden death after sustained restraint following self-administration of the designer drug alpha-pyrrolidinovalerophenone. Int. J. Cardiol. 2014, 172:263-265.
19. Al-Saffar Y., Stephanson N.N., Beck O. Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population. J. Chromatogr. B Anal. Technol. Biomed Life Sci. 2013, 930:112-120.
20. Bell C., George C., Kicman A.T., Traynor A. Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs. Drug Test Anal. 2011, 3:496-504.
21. Bjornstad K., Beck O., Helander A. A multi-component LC-MS/MS method for detection of ten plant-derived psychoactive substances in urine. J. Chromatogr. B Anal. Technol. Biomed Life Sci. 2009, 877:1162-1168.
22. Wohlfarth A., Weinmann W., Dresen S. LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Anal. Bioanal. Chem. 2010, 396:2403-2414.
23. Helander A., Backberg M., Hulten P., Al-Saffar Y., Beck O. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. Forensic Sci. Int. 2014, 243:23-29.
24. Oiestad E.L., Johansen U., Christophersen A.S., Karinen R. Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS. Bioanalysis 2013, 5:2257-2268.
25. Strano-Rossi S., Odoardi S., Fisichella M., Anzillotti L., Gottardo R., Tagliaro F. Screening for new psychoactive substances in hair by ultrahigh performance liquid chromatography-electrospray ionization tandem mass spectrometry. J. Chromatogr. A 2014, 1372C:145-156.
26. Sundstrom M., Pelander A., Angerer V., Hutter M., Kneisel S., Ojanpera I. A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine. Anal. Bioanal. Chem. 2013, 405:8463-8474.
27. Scheidweiler K.B., Huestis M.A. Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2014, 1327:105-117.
28. Ambach L., Hernández Redondo A., König S., Weinmann W. Rapid and simple LC-MS/MS screening of 64 novel psychoactive substances using dried blood spots. Drug Test Anal. 2014, 6:367-375.
29. Kneisel S., Auwärter V. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. J. Mass Spectrom. 2012, 47:825-835.
30. Huppertz L.M., Kneisel S., Auwärter V., Kempf J. A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization. J. Mass Spectrom. 2014, 49:117-127.
31. Rezaee M., Assadi Y., Milani Hosseini M.R., Aghaee E., Ahmadi F., Berijani S. Determination of organic compounds in water using dispersive liquid-liquid microextraction. J. Chromatogr. A 2006, 1116:1-9.
32. Berijani S., Assadi Y., Anbia M., Milani Hosseini M.R., Aghaee E. Dispersive liquid-liquid microextraction combined with gas chromatography-flame photometric detection. Very simple, rapid and sensitive method for the determination of organophosphorus pesticides in water. J. Chromatogr. A 2006, 1123:1-9.
33. Fernandez P., Regenjo M., Bermejo A.M., Fernandez A.M., Lorenzo R.A., Carro A.M. Analysis of drugs of abuse in human plasma by dispersive liquid-liquid microextraction and high-performance liquid chromatography. J. Appl. Toxicol. 2015, 35:418-425.
34. Cabarcos P., Angel Cocho J., Moreda A., Miguez M., Jesus Tabernero M., Fernandez P., Maria Bermejo A. Application of dispersive liquid-liquid microextraction for the determination of phosphatidylethanol in blood by liquid chromatography tandem mass spectrometry. Talanta 2013, 111:189-195.
35. Fisichella M., Odoardi S., Strano-Rossi S. High-throughput dispersive liquid/liquid microextraction (DLLME) method for the rapid determination of drugs of abuse, benzodiazepines and other psychotropic medications in blood samples by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and application to forensic cases. Microchem. J. 2015, 123:33-41.
36. Deruiter J., Hayes L., Valaer A., Clark C.R., Noggle F.T. Methcathinone and designer analogs - synthesis, stereochemical analysis, and analytical properties. J. Chromatogr. Sci. 1994, 32:552-564.
37. Davies S., Wood D.M., Smith G., Button J., Ramsey J., Archer R., Holt D.W., Dargan P.I. Purchasing 'legal highs' on the internet-is there consistency in what you get?. QJM Int. J. Med. 2010, 103:489-493.
38. Strano Rossi S., Odoardi S., Gregori A., Peluso G., Ripani L., Ortar G., Serpelloni G., Romolo F.S. An analytical approach to the forensic identification of different classes of new psychoactive substances (NPSs) in seized materials. Rapid Commun. Mass Spectrom. 2014, 28:1904-1916.
39. FDA, Bioanalytical Method Validation (Accesed 28.05.2014). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM368107.pdf.
40. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
41. de Castro A., Lendoiro E., Fernández-Vega H., Steinmeyer S., López-Rivadulla M., Cruz A. Liquid chromatography tandem mass spectrometry determination of selected synthetic cathinones and two piperazines in oral fluid. Cross reactivity study with an on-site immunoassay device. J. Chromatogr. A 2014, 1374:93-101.
42. Salomone A., Luciano C., Di Corcia D., Gerace E., Vincenti M. Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers. Drug Test Anal. 2014, 6:126-134.
43. Hutter M., Kneisel S., Auwarter V., Neukamm M.A. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2012, 903:95-101.
44. Rust K.Y., Baumgartner M.R., Dally A.M., Kraemer T. Prevalence of new psychoactive substances: a retrospective study in hair. Drug Test Anal. 2012, 4:402-408.
45. LaPointe J., Musselman B., O'Neill T., Shepard J.R. Detection of bath salt synthetic cathinones and metabolites in urine via DART-MS and solid phase microextraction. J. Am. Soc. Mass Spectrom. 2015, 26:159-165.
46. Simões S.S., Silva I., Ajenjo A.C., Dias M.J. Validation and application of an UPLC-MS/MS method for the quantification of synthetic cannabinoids in urine samples and analysis of seized materials from the Portuguese market. Forensic Sci. Int. 2014, 243:117-125.
47. Ammann D., McLaren J.M., Gerostamoulos D., Beyer J. Detection and quantification of new designer drugs in human blood: Part 2 - designer cathinones. J. Anal. Toxicol. 2012, 36:381-389.
48. Sørensen L.K. Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2011, 879:727-736.